Ali Behbahani Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ali Behbahani.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ali Behbahani. Ali Behbahani is 10% Owner in Marker Therapeutics, Inc. ($MRKR) and Director in NEVRO CORP ($NVRO) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and Director in Nkarta, Inc. ($NKTX).

Latest Insider Trading Transactions of Ali Behbahani

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases00000015
Value of Purchases ($)00000039,839,383
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 22 2021BDTXBlack Diamond Ther ...Behbahani AliDirectorGrantA24.0154713,1335470 to 547
Mar 18 2021MRKRMarker Therapeutic ...Behbahani Ali10% OwnerBuyP1.755,714,2859,999,99910,714,2855 M to 10.7 M (+114.29 %)
Dec 07 2020RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerOption ExerciseP0.00258,7070258,707
Dec 07 2020RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerOption ExerciseP0.755,239,2543,910,5795,239,254
Dec 07 2020RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerBuyP0.624,398,6022,735,9306,451,0562.1 M to 6.5 M (+214.31 %)
Sep 22 2020MTCRMetacrine, Inc.Behbahani Ali10% OwnerOption ExerciseC0.00332,96400
Sep 22 2020MTCRMetacrine, Inc.Behbahani Ali10% OwnerOption ExerciseC0.001,958,33300
Sep 22 2020MTCRMetacrine, Inc.Behbahani Ali10% OwnerBuyP13.00769,2309,999,9903,060,5272.3 M to 3.1 M (+33.57 %)
Sep 22 2020MTCRMetacrine, Inc.Behbahani Ali10% OwnerBuyC0.00332,96402,291,2972 M to 2.3 M (+17.00 %)
Sep 22 2020MTCRMetacrine, Inc.Behbahani Ali10% OwnerBuyC0.001,958,33301,958,3330 to 2 M
Aug 14 2020CRSPCRISPR Therapeutic ...Behbahani AliDirectorBuyJ0.00140140 to 14
Aug 14 2020CRSPCRISPR Therapeutic ...Behbahani AliDirectorBuyJ0.00570256199 to 256 (+28.64 %)
Jul 28 2020GNCAGENOCEA BIOSCIENCE ...Behbahani AliDirectorOption ExerciseP2.253,151,2607,090,3353,151,260
Jul 28 2020GNCAGENOCEA BIOSCIENCE ...Behbahani AliDirectorBuyP2.253,151,2607,090,33510,376,9367.2 M to 10.4 M (+43.61 %)
Jul 13 2020NKTXNkarta, Inc.Behbahani AliDirectorOption ExerciseA18.0010,700192,60010,700
Jul 13 2020NKTXNkarta, Inc.Behbahani AliDirectorOption ExerciseA18.0010,700192,60010,700
Jul 01 2020AKUSAkouos, Inc.Behbahani Ali10% OwnerOption ExerciseC0.001,199,97600
Jul 01 2020AKUSAkouos, Inc.Behbahani Ali10% OwnerOption ExerciseC0.001,992,23800
Jul 01 2020AKUSAkouos, Inc.Behbahani Ali10% OwnerOption ExerciseC0.00513,75800
Jul 01 2020AKUSAkouos, Inc.Behbahani Ali10% OwnerBuyP17.00588,2359,999,9954,294,2073.7 M to 4.3 M (+15.87 %)
Jul 01 2020AKUSAkouos, Inc.Behbahani Ali10% OwnerBuyC0.001,199,97603,705,9722.5 M to 3.7 M (+47.88 %)
Jul 01 2020AKUSAkouos, Inc.Behbahani Ali10% OwnerBuyC0.001,992,23802,505,996513.8 K to 2.5 M (+387.78 %)
Jul 01 2020AKUSAkouos, Inc.Behbahani Ali10% OwnerBuyC0.00513,7580513,7580 to 513.8 K
Jul 01 2020ADAPAdaptimmune Therap ...Behbahani AliDirectorOption ExerciseA1.67184,258307,711184,258
Jun 19 2020GNCAGENOCEA BIOSCIENCE ...Behbahani AliDirectorOption ExerciseA2.2215,00033,30015,000
Jun 15 2020CRSPCRISPR Therapeutic ...Behbahani AliDirectorOption ExerciseA59.7015,000895,50015,000
Jun 10 2020OYSTOyster Point Pharm ...Behbahani AliDirectorGrantA0.006,60006,6000 to 6.6 K
Jun 10 2020OYSTOyster Point Pharm ...Behbahani AliDirectorGrantA0.006,60006,6000 to 6.6 K
Apr 13 2020TRVITrevi Therapeutics ...Behbahani Ali10% OwnerOption ExerciseX0.001,500,0001,5000
Apr 13 2020TRVITrevi Therapeutics ...Behbahani Ali10% OwnerSellS2.665641,5005,937,9985.9 M to 5.9 M (-0.01 %)
Apr 13 2020TRVITrevi Therapeutics ...Behbahani Ali10% OwnerBuyX0.001,500,0001,5005,938,5624.4 M to 5.9 M (+33.79 %)
Feb 05 2020BDTXBlack Diamond Ther ...Behbahani AliDirectorOption ExerciseC0.001,422,86200
Feb 05 2020BDTXBlack Diamond Ther ...Behbahani AliDirectorOption ExerciseC0.006,565,29000
Feb 05 2020BDTXBlack Diamond Ther ...Behbahani AliDirectorBuyP19.00800,00015,200,0003,448,7572.6 M to 3.4 M (+30.20 %)
Feb 05 2020BDTXBlack Diamond Ther ...Behbahani AliDirectorBuyC0.00471,80002,648,7572.2 M to 2.6 M (+21.67 %)
Feb 05 2020BDTXBlack Diamond Ther ...Behbahani AliDirectorBuyC0.002,176,95702,176,9570 to 2.2 M
Jan 28 2020ADAPAdaptimmune Therap ...Behbahani AliDirectorBuyP0.677,500,0005,000,25019,500,00012 M to 19.5 M (+62.50 %)
Dec 26 2019RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerOption ExerciseP0.00900,9000900,900
Dec 26 2019RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerOption ExerciseP0.679,009,0005,999,9949,009,000
Jul 24 2019MIRMMirum Pharmaceutic ...Behbahani Ali10% OwnerOption ExerciseC0.0029,889,94500
Jul 24 2019MIRMMirum Pharmaceutic ...Behbahani Ali10% OwnerOption ExerciseC0.0029,889,94500
Jul 24 2019MIRMMirum Pharmaceutic ...Behbahani Ali10% OwnerBuyP15.00450,0006,750,0004,186,2433.7 M to 4.2 M (+12.04 %)
Jul 24 2019MIRMMirum Pharmaceutic ...Behbahani Ali10% OwnerBuyP15.00450,0006,750,0004,186,2433.7 M to 4.2 M (+12.04 %)
Jul 24 2019MIRMMirum Pharmaceutic ...Behbahani Ali10% OwnerBuyC0.003,736,24303,736,2430 to 3.7 M
Jul 24 2019MIRMMirum Pharmaceutic ...Behbahani Ali10% OwnerBuyC0.003,736,24303,736,2430 to 3.7 M
Jul 19 2019GNCAGENOCEA BIOSCIENCE ...Behbahani AliDirectorOption ExerciseA3.665,62520,5885,625
Jul 03 2019ADAPAdaptimmune Therap ...Behbahani AliDirectorOption ExerciseA0.61234,407142,988234,407
Jun 25 2019GNCAGENOCEA BIOSCIENCE ...Behbahani AliDirectorBuyP3.502,857,1429,999,9977,225,6764.4 M to 7.2 M (+65.40 %)
Jun 25 2019GNCAGENOCEA BIOSCIENCE ...Behbahani AliDirectorBuyP3.502,857,1429,999,9977,225,6764.4 M to 7.2 M (+65.40 %)
Jun 13 2019CRSPCRISPR Therapeutic ...Behbahani AliDirectorOption ExerciseA43.5215,000652,80015,000
May 13 2019TRVITrevi Therapeutics ...Behbahani Ali10% OwnerOption ExerciseC0.0017,099,31500
May 13 2019TRVITrevi Therapeutics ...Behbahani Ali10% OwnerBuyP10.001,500,00015,000,0004,438,5622.9 M to 4.4 M (+51.05 %)
May 13 2019TRVITrevi Therapeutics ...Behbahani Ali10% OwnerBuyP10.001,000,00010,000,0002,938,5621.9 M to 2.9 M (+51.58 %)
May 13 2019TRVITrevi Therapeutics ...Behbahani Ali10% OwnerBuyC0.001,938,56201,938,5620 to 1.9 M
May 09 2019RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerOption ExerciseP0.00256,7000256,700
May 09 2019RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerOption ExerciseP1.083,703,7044,000,0003,703,704
May 09 2019RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerBuyP1.081,136,7041,227,6402,052,454915.8 K to 2.1 M (+124.13 %)
Feb 19 2019GNCAGENOCEA BIOSCIENCE ...Behbahani AliDirectorOption ExerciseP0.572,487,0671,406,6852,487,067
Feb 19 2019GNCAGENOCEA BIOSCIENCE ...Behbahani AliDirectorBuyP0.479,948,2694,688,61934,948,26925 M to 34.9 M (+39.79 %)
Sep 10 2018ADAPAdaptimmune Therap ...Behbahani AliDirectorBuyP1.6712,000,00020,000,40012,000,0000 to 12 M
Jun 26 2018ADAPAdaptimmune Therap ...Behbahani AliDirectorOption ExerciseA2.18154,809337,484154,809
Jun 25 2018GNCAGENOCEA BIOSCIENCE ...Behbahani AliDirectorOption ExerciseA0.9950,00049,50050,000
Jun 15 2018CRSPCRISPR Therapeutic ...Behbahani AliDirectorOption ExerciseA59.3115,000889,65015,000
Jun 15 2018CRSPCRISPR Therapeutic ...Behbahani AliDirectorOption ExerciseA59.3115,000889,65015,000
May 23 2018NVRONEVRO CORPBehbahani AliDirectorGrantA0.003,78505,3901.6 K to 5.4 K (+235.83 %)
May 23 2018NVRONEVRO CORPBehbahani AliDirectorGrantA0.003,78505,3901.6 K to 5.4 K (+235.83 %)
Feb 12 2018GNCAGENOCEA BIOSCIENCE ...Behbahani AliDirectorOption ExerciseA0.9825,00024,50025,000
Sep 15 2017NVRONEVRO CORPBehbahani AliDirectorBuyJ0.00801,6051.6 K to 1.6 K (+0.50 %)
Sep 15 2017NVRONEVRO CORPBehbahani AliDirectorBuyJ0.003201,5971.6 K to 1.6 K (+2.04 %)
Jul 03 2017ADAPAdaptimmune Therap ...Behbahani AliDirectorOption ExerciseA0.75220,788165,591220,788
Jun 02 2017CRSPCRISPR Therapeutic ...Behbahani AliDirectorOption ExerciseA13.6215,000204,30015,000
May 30 2017NVRONEVRO CORPBehbahani AliDirectorOption ExerciseA74.073,545262,5783,545
May 30 2017NVRONEVRO CORPBehbahani AliDirectorGrantA0.001,51801,56547 to 1.6 K (+3,229.79 %)
Nov 15 2016NVRONEVRO CORPBehbahani AliDirectorBuyJ0.00304744 to 47 (+6.82 %)
Nov 15 2016NVRONEVRO CORPBehbahani AliDirectorBuyJ0.001904425 to 44 (+76.00 %)
Oct 20 2016CRSPCRISPR Therapeutic ...Behbahani AliDirectorOption ExerciseA14.0030,000420,00030,000
Aug 12 2016ADAPAdaptimmune Therap ...Behbahani AliDirectorOption ExerciseA1.27184,562234,394184,562
May 20 2016NVRONEVRO CORPBehbahani AliDirectorOption ExerciseA63.393,240205,3843,240
Dec 03 2015NVRONEVRO CORPBehbahani AliDirectorBuyJ0.00302522 to 25 (+13.64 %)
Dec 03 2015NVRONEVRO CORPBehbahani AliDirectorBuyJ0.00220220 to 22
Jun 01 2015NVRONEVRO CORPBehbahani AliDirectorOption ExerciseA50.504,182211,1914,182
Nov 07 2014NVRONEVRO CORPBehbahani AliDirectorOption ExerciseA18.008,477152,5868,477

Page:   1